376 related articles for article (PubMed ID: 15124331)
1. Growing against the grain.
Boyle M
Fortune; 2004 May; 149(9):148-9, 152, 154 passim. PubMed ID: 15124331
[No Abstract] [Full Text] [Related]
2. Biotech's new colossus. Move over, Big Pharma. Amgen boasts better growth.
Stipp D
Fortune; 2002 Apr; 145(8):144-6, 148, 150. PubMed ID: 11961884
[No Abstract] [Full Text] [Related]
3. Pfizer and its competitive marketing challenges.
Carter T
J Hosp Mark Public Relations; 2003; 14(2):85-97. PubMed ID: 14753324
[TBL] [Abstract][Full Text] [Related]
4. Is it too late to save Schering?
Simons J
Fortune; 2003 Sep; 148(5):145-6, 148, 150. PubMed ID: 14509911
[No Abstract] [Full Text] [Related]
5. DPI delivers biotechnology superstore. Discovery Partners International.
Glaser V
Nat Biotechnol; 1998 Dec; 16(13):1302. PubMed ID: 9853596
[No Abstract] [Full Text] [Related]
6. Hyseq-Variagenics merger signals end of the line.
Hodgson J
Nat Biotechnol; 2003 Jan; 21(1):5. PubMed ID: 12511895
[No Abstract] [Full Text] [Related]
7. Genzyme and Isis strike megadeal.
Mack GS
Nat Biotechnol; 2008 Mar; 26(3):251-3. PubMed ID: 18327216
[No Abstract] [Full Text] [Related]
8. Kiran Mazumdar-Shaw.
Jayaraman KS
Nat Biotechnol; 2005 Jan; 23(1):11. PubMed ID: 15637602
[No Abstract] [Full Text] [Related]
9. This Dutchman is flying.
Watson N
Fortune; 2003 Jun; 147(13):89-90. PubMed ID: 12827720
[No Abstract] [Full Text] [Related]
10. What mergers can do for you.
Acharya A
Nat Biotechnol; 2011 Jun; 29(6):477-9. PubMed ID: 21796820
[No Abstract] [Full Text] [Related]
11. Row over industry link-up splits staff of Spanish lab.
Fernandez Hermana LA
Nature; 1994 Dec; 372(6507):586. PubMed ID: 7990935
[No Abstract] [Full Text] [Related]
12. Hot concepts in strategy.
Beckham JD
Healthc Forum J; 1997; 40(1):43-7. PubMed ID: 10164206
[No Abstract] [Full Text] [Related]
13. Pfizer swallows Wyeth, validates niche buster.
Sheridan C
Nat Biotechnol; 2009 Mar; 27(3):218-9. PubMed ID: 19270661
[No Abstract] [Full Text] [Related]
14. Investing in risk management.
Fiscus PW
Nat Biotechnol; 1997 Jan; 15(1):88-9. PubMed ID: 9035113
[No Abstract] [Full Text] [Related]
15. Mike Varney.
Varney M; Mullard A
Nat Rev Drug Discov; 2015 Mar; 14(3):158-9. PubMed ID: 25677359
[No Abstract] [Full Text] [Related]
16. The quiet revolution.
Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
[No Abstract] [Full Text] [Related]
17. Competitive collaboration in the pharmaceutical and biotechnology industry.
Bingham A; Ekins S
Drug Discov Today; 2009 Dec; 14(23-24):1079-81. PubMed ID: 19835979
[No Abstract] [Full Text] [Related]
18. Antisoma-Roche deal--a new kind of buyout?
Mitchell P
Nat Biotechnol; 2003 Jan; 21(1):3. PubMed ID: 12511894
[No Abstract] [Full Text] [Related]
19. Changing partners.
Nat Biotechnol; 2002 Sep; 20(9):855. PubMed ID: 12205487
[No Abstract] [Full Text] [Related]
20. The case for entrepreneurship in R&D in the pharmaceutical industry.
Douglas FL; Narayanan VK; Mitchell L; Litan RE
Nat Rev Drug Discov; 2010 Sep; 9(9):683-9. PubMed ID: 20725093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
